Search

Home > GRACEcast Lung Cancer Video > Timing of Second Generation ALK Inhibitors: First Line vs. Treatment after Acquired Resistance
Podcast: GRACEcast Lung Cancer Video
Episode:

Timing of Second Generation ALK Inhibitors: First Line vs. Treatment after Acquired Resistance
Category: Science & Medicine
Duration: 00:02:20
Publish Date: 2016-04-13 14:00:00
Description:

Dr. Ross Camidge, University of Colorado, addresses the question of whether to use a second generation ALK inhibitor as first line therapy or only after acquired resistance to crizotinib.
Total Play: 0